Brewer Lane Ventures

Brewer Lane Ventures is a Boston-based early-stage fintech investor with a thesis centered on financial services, insurance, and adjacent regulated industries. While not a healthcare specialist, the fund has meaningful potential overlap with healthcare AI through the insurtech and health-insurance lens — payers, benefits, claims, and revenue-cycle businesses live at the seam between fintech and health-tech. Stage focus is seed and Series A, with check sizes plausibly $1M to $5M and a willingness to lead in their wheelhouse. Founders who should approach: healthcare AI companies whose buyer is a payer, TPA, or insurance carrier — claims automation, prior authorization, fraud detection, member engagement, employer benefits — particularly if the team has insurance industry credibility and can articulate a regulatory and compliance narrative that resonates with insurance-savvy investors. Founders who should not approach: clinical-side AI selling to providers without an insurance angle, biotech, medical devices, and consumer health apps. Brewer Lane’s value-add is in fintech and insurance domain expertise, board-level operating experience in regulated industries, and downstream connections to insurance carriers as customers and acquirers. Entry path is warm introduction through Boston-area fintech and insurtech operators, portfolio founders, or co-investors in the insurance VC ecosystem. Their LinkedIn page lists partners and portfolio that map the typical deal. Be prepared to discuss regulatory pathways, MLR considerations, state-level insurance commissioner dynamics, and the specific payer or employer customer pipeline you have built or plan to build. Insurance-flavored healthcare AI is the right fit; clinical-only is not.